Conquer Cancer Foundation of the American

“Conquer cancer does not have members. Directors of conquer cancer are appointed and subject to removal by the board of directors of asco, except for directors serving ex-officio.”

“The board of directors of conquer cancer may vote to amend or repeal the bylaws of conquer cancer, but the board of directors of asco must approve an amendment or repeal of the bylaws to be effective. Conquer cancer may not amend its articles of incorporation without providing to asco written notice of the proposed amendment at least thirty (30) days in advance.”

“A copy of the tax return, including all applicable schedules, was provided to the board of directors, chief financial officer and general counsel for review and comment prior to its filing.”

“Conquer cancer maintains a number of written conflict of interest policies and standards regarding the disclosure and management of conflicts of interest. These policies and standards cover all conquer cancer staff, directors, officers, committee members, and any person in a relationship with these individuals involving the sharing of income or assets (e.g., spouse, dependent children). Under conquer cancer's policies, covered individuals are asked to disclose financial interests in or other relationships with entities that have relevant commercial interests, including employment or leadership positions,consultant or advisory roles, stock ownership, honoraria, research funding, and service as an expert witness. Completion of a disclosure form is required at the initiation of service, and updated annually thereafter or when any material changes occur. Conquer cancer's conflict of interest policies are intended to help guide the management of actual, potential, and perceived conflicts of interest through disclosure of financial interests or other relationships. Where the nature and extent of a financial relationship suggest disclosure is not adequate to manage a real or potential conflict, covered individuals are required to recuse themselves from decision making. Recusal may be self-selected, or may be requested by the committee chair, officer, or executive-level staff members. In addition, when conquer cancer is contemplating entering into a transaction or arrangement that might benefit the private interest of any "interested person" (i.e., a conquer cancer director, principal officer, or member of a committee with board delegated powers who has a direct or indirect financial interest in the transaction), it must follow a specific procedure to manage the conflict, including considering alternative transactions that would not give rise to a conflict of interest.”

“The chief executive officer of conquer cancer, the executive vice chair of conquer cancer, and the chief financial officer of conquer cancer serve as employees of asco. Information regarding their compensation and the process for determining their compensation, including review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision, are described in the irs form 990 of asco. Conquer cancer staff are employees of asco who are leased to conquer cancer. Applicable information regarding their compensation is described in the irs form 990 of asco. Conquer cancer does not pay compensation to these individuals.”

“Conquer cancer's governing documents are available to the public from conquer cancer upon request. Conquer cancer's articles of incorporation are also available to the public through the virginia state corporation commission. Conflict of interest policies and standards are posted on conquer cancer's website. The annual report of conquer cancer is posted on conquer cancer's website and is available to the public from conquer cancer upon request. The audited financial statements of conquer cancer are posted on conquer cancer's website.”

“The audit oversight process has not changed from the prior year.”